Lv1
18 积分 2026-03-04 加入
Metabolic fitness landscapes predict the evolution of antibiotic resistance
20天前
已完结
First virological control after >30 years of antiretroviral therapy in extensively drug-resistant HIV: potential role of lenacapavir plus ibalizumab
25天前
已完结
Cefepime/Zidebactam: First Approval
1个月前
已完结
Emerging resistance mechanisms to newer β-lactams in Pseudomonas aeruginosa
1个月前
已完结
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem
2个月前
已完结
First Report of Treatment-Emergent Resistance to Cefepime-Zidebactam in Pseudomonas aeruginosa
2个月前
已完结
In vitro activity and resistance mechanisms of sulbactam/durlobactam against Acinetobacter baumannii clinical isolates in China (2019–2020)
2个月前
已完结
In vitro antimicrobial activity of six novel β-lactam and β-lactamase inhibitor combinations and cefiderocol against NDM-producing Enterobacterales in China
2个月前
已完结
Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa
3个月前
已完结
Emergence of cefiderocol resistance mediated by blaAFM-1 overexpression and FptA mutations in clinical carbapenem-resistant Pseudomonas aeruginosa isolates
3个月前
已关闭
皖公网安备34019202002308
